Recent Updates — HCTI

Healthcare Triangle, Inc. effected a one-for-twenty (1:20) reverse stock split of its common stock effective October 26, 2026, at 12:01 a.m. Eastern Time. The transaction reduced the number of issued and outstanding shares from approximately 17,730,008 to 886,587. This action was taken to address a Staff Delisting Determination received on October 1, 2026, regarding failure to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company intends to present this split as part of its plan to regain compliance during an appeal hearing scheduled for November 5, 2026. Healthcare Triangle provides digital transformation solutions, including managed services and data analytics, for healthcare and life sciences organizations.

Healthcare Triangle, Inc. stockholders approved amendments to the Certificate of Incorporation authorizing one or more reverse splits of common stock at ratios ranging from 1-for-2 to 1-for-25, with the exact ratio to be determined by the Board. The vote also passed a proposal exempting future issuances under Nasdaq Listing Rule 5635(d) and amended the 2020 Stock Incentive Plan to remove reverse split adjustments. Approximately 53.69% of voting shares were present or represented at the virtual special meeting on October 23, 2026. Healthcare Triangle operates in the healthcare technology sector.

On October 1, 2026, Healthcare Triangle, Inc. received a Staff Delisting Determination from Nasdaq for failing to meet the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). The company is ineligible for a standard compliance period because it executed reverse stock splits over the prior two years with a cumulative ratio of 1-for-14,940 (specifically 1-for-249 on August 1, 2025, and 1-for-60 on February 10, 2026). Unless an appeal to the Nasdaq Hearings Panel is filed by October 8, 2026, trading will be suspended on October 12, 2026. The company intends to request a hearing and present a compliance plan that may include another reverse split. Healthcare Triangle, Inc. operates in the healthcare sector, providing medical staffing and related services.

Healthcare Triangle, Inc. entered into a First Amendment to its Equity Purchase Agreement with Hudson Global Ventures, LLC on September 22, 2026. The amendment reduces the maximum amount sellable per Put Notice from $2,500,000 to $250,000 and increases the minimum price per share threshold from $0.01 to $0.10. It also adds a Change of Control provision preventing the Company from delivering Put Notices upon such an event. Healthcare Triangle, Inc. operates in the healthcare sector, providing medical staffing and related services.

Healthcare Triangle, Inc. entered into a Separation and Distribution Agreement with its wholly-owned subsidiary Teyame AI Holdings, Inc., to spin off Teyame from the parent company. The transaction involves distributing a minority interest of Teyame common stock pro rata to Healthcare Triangle shareholders, while Healthcare Triangle retains majority ownership. Teyame will operate as a separate public company listed on Nasdaq after filing a Form 10 registration statement. The distribution is expected to be taxable under U.S. federal income tax laws. Healthcare Triangle remains jointly liable for unpaid acquisition consideration related to Teyame's Spanish subsidiaries and has entered into a Transition Services Agreement to provide interim administrative, legal, and IT support. This company operates in the healthcare technology sector.

Healthcare Triangle issued 12,546,540 shares of common stock on July 28, 2026, to satisfy obligations from two previously shareholder-approved transactions. The company delivered 9,718,373 shares to entities directed by Teyame AI LLC for the acquisition closing and issued 2,828,167 shares under a Securities Exchange Agreement with SecureKloud Technologies Ltd. These issuances increased total common stock outstanding to 14,644,322 shares. The transaction supports compliance with Nasdaq’s new $5 million Market Value of Listed Securities standard, resulting in an approximate market value of $23,870,244 based on a July 28 closing price of $1.63 per share. Healthcare Triangle provides digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations.